Neostigmine
The standard reversal agent for non-depolarizing neuromuscular blockade, Neostigmine inhibits acetylcholinesterase. It requires mandatory co-administration with an anticholinergic to prevent bradycardia and secretions. Objective confirmation of adequate reversal with a nerve stimulator is essential before considering extubation.
